Arsenic and human health effects: A review

Environmental Toxicology and Pharmacology

Volumn 40, Issue 3, 2015, Pages 828-846

  Mohammed Abdul, Khaja Shameem ^a   Jayasinghe, Sudheera Sammanthi ^b   Chandana, Ediriweera P S ^a   Jayasumana, Channa ^c   De Silva, P Mangala C S ^a  

^a UNIVERSITY OF RUHUNA   (Sri Lanka)

^b UNIVERSITY OF RUHUNA   (Sri Lanka)

^c RAJARATA UNIVERSITY OF SRI LANKA   (Sri Lanka)

Author keywords

Arsenic; Environmental exposure; Epigenesis; Neoplasms; Organs at risk; Toxicity

Indexed keywords

ARSENIC; CREATININE; DRINKING WATER; GLOBULIN; UREA;

ACETYLATION; ADAMTS9 GENE; ALZHEIMER DISEASE; ANEMIA; AUTOIMMUNE DISEASE; BASAL CELL CARCINOMA; BLACK FOOT DISEASE; BLADDER CANCER; BRAIN DISEASE; BREATHING DISORDER; BRONCHIECTASIS; BRONCHITIS; CANCER GROWTH; CAPN10 GENE; CARCINOGENESIS; CARDIOMYOPATHY; CARDIOVASCULAR DISEASE; CAROTID ATHEROSCLEROSIS; CAUSE OF DEATH; CHRONIC KIDNEY DISEASE; COGNITIVE DEFECT; COMA; COUGHING; CYTOTOXICITY; DAPK GENE; DIABETES MELLITUS; DIARRHEA; DYSPEPSIA; ENDOCYTOSIS; EPIGENETICS; FETUS DEATH; GASTROINTESTINAL SYMPTOM; GENE EXPRESSION; GENETIC VARIABILITY; GLOMERULOPATHY; GONAD DYSFUNCTION; GROWTH RETARDATION; HALLUCINATION; HEADACHE; HEALTH HAZARD; HEART ARRHYTHMIA; HEMOLYSIS; HEPATOMEGALY; HISTONE PHOSPHORYLATION; HUMAN; HYPERKETEROSIS; HYPOTHYROIDISM; IMMUNE DEFICIENCY; IMMUNOTOXICITY; INFANT MORTALITY; INNATE IMMUNITY; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN RESISTANCE; INTEGUMENTARY SYSTEM; INTERSTITIAL NEPHRITIS; ISCHEMIC HEART DISEASE; KERATOSIS; KIDNEY CANCER; LARYNGITIS; LEARNING DISORDER; LEUKOPENIA; LIPID PEROXIDATION; LIVER CANCER; LIVER CIRRHOSIS; LIVER FAILURE; LIVER FIBROSIS; LIVER INJURY; LIVER TOXICITY; LUNG CANCER; LUNG DISEASE; MELANOSIS; MEMORY DISORDER; MORTALITY; MYOCARDIAL DISEASE; NAUSEA; NEPHROTOXICITY; NEUROTOXICITY; NON INSULIN DEPENDENT DIABETES MELLITUS; NON MELANOMA SKIN CANCER; NONHUMAN; NOTCH2 GENE; OXIDATIVE STRESS; P16 GENE; PAIN; PARESTHESIA; PERIPHERAL NEUROPATHY; PERIPHERAL VASCULAR DISEASE; PHAGOCYTOSIS; PRIORITY JOURNAL; PROSTATE CANCER; PROTEINURIA; QRS COMPLEX; QT INTERVAL; QT PROLONGATION; RESPIRATORY TRACT INFECTION; REVIEW; RHINITIS; SEIZURE; SENSORIMOTOR NEUROPATHY; SKIN CANCER; SKIN CARCINOMA; SKIN DISEASE; SKIN PIGMENTATION; SNP 43 GENE; THROMBOCYTOPENIA; TUBERCULOSIS; UBIQUITINATION; VOMITING; CHEMICALLY INDUCED; DRUG EFFECTS; ENVIRONMENTAL EXPOSURE; GENETIC EPIGENESIS; GENETICS; HEMATOLOGIC DISEASE; IMMUNOPATHOLOGY; MUTATION; NEOPLASM; NEUROLOGIC DISEASE; RESPIRATORY TRACT DISEASE;

ARSENIC; CARDIOVASCULAR DISEASES; ENVIRONMENTAL EXPOSURE; EPIGENESIS, GENETIC; HEMATOLOGIC DISEASES; HUMANS; IMMUNE SYSTEM DISEASES; MUTATION; NEOPLASMS; NERVOUS SYSTEM DISEASES; RESPIRATORY TRACT DISEASES;

EID: 84945185356     PISSN: 13826689     EISSN: 18727077     Source Type: Journal    
DOI: 10.1016/j.etap.2015.09.016     Document Type: Review

References (258)

1. Abir T., Rahman B., D'Este C., Farooq A., Milton A.H. The association between chronic arsenic exposure and hypertension: a meta-analysis. J. Toxicol. 2012, 2012:1-13.
2. Ahmed S., Ahsan K.B., Kippler M., Mily A., Wagatsuma Y., Hoque A.M.W., Ngom P.T., Arifeen S.E., Raqib R., Vahter M. In utero arsenic exposure is associated with impaired thymic function in newborns possibly via oxidative stress and apoptosis. Toxicol. Sci. 2012, 129:305-314.
3. Ahmed S., Moore S.E., Kippler M., Gardner R., Hawlader M.D., Wagatsuma Y., Raqib R., Vahter M. Arsenic exposure and cell-mediated immunity in pre-school children in rural Bangladesh. Toxicol. Sci. 2014, 141:166-175.
4. Ahsan H., Chen Y., Parvez F., Zablotska L., Argos M., Hussain I., Momotaj H., Levy D., Cheng Z., Slavkovich V., van Geen A., Howe G.R., Graziano J.H. Arsenic exposure from drinking water and risk of premalignant skin lesions in Bangladesh: baseline results from the Health Effects of Arsenic Longitudinal Study. Am. J. Epidemiol. 2006, 163:1138-1148.
5. Ahsan H., Perrin M., Rahman A., Parvez F., Stute M., Zheng Y., Milton A.H., Brandt-Rauf P., van Geen A., Graziano J. Associations between drinking water and urinary arsenic levels and skin lesions in Bangladesh. J. Occup. Environ. Med. 2000, 42:1195-1201.
6. Amster E., Tiwary A., Schenker M.B. Case report: potential arsenic toxicosis secondary to herbal kelp supplement. Environ. Health Perspect. 2007, 115:606-608.
7. Aoyama K., Watabe M., Nakaki T. Regulation of neuronal glutathione synthesis. J. Pharmacol. Sci. 2008, 108:227-238.
8. Argos M., Chen L., Jasmine F., Tong L., Pierce B.L., Roy S., Paul-Brutus R., Gamble M.V., Harper K.N., Parvez F. Gene-specific differential DNA methylation and chronic arsenic exposure in an epigenome-wide association study of adults in Bangladesh. Environ. Health Perspect. 2015, 123:64-71.
9. Argos M., Kalra T., Rathouz P.J., Chen Y., Pierce B., Parvez F., Islam T., Ahmed A., Rakibuz-Zaman M., Hasan R., Sarwar G., Slavkovich V., van Geen A., Graziano J., Ahsan H. Arsenic exposure from drinking water, and all-cause and chronic-disease mortalities in Bangladesh (HEALS): a prospective cohort study. Lancet 2010, 376:252-258.
10. Ashcroft F.M., Rorsman P. Diabetes mellitus and the beta cell: the last ten years. Cell 2012, 148:1160-1171.
11. Axelson O., Dahlgren E., Jansson C.D., Rehnlund S.O. Arsenic exposure and mortality: a case-referent study from a Swedish copper smelter. Br. J. Ind. Med. 1978, 35:8-15.
12. Bailey K.A., Fry R.C. Arsenic-associated changes to the epigenome: what are the functional consequences?. Curr. Environ. Health Rep. 2014, 1:22-34.
13. Banerjee N., Banerjee S., Sen R., Bandyopadhyay A., Sarma N., Majumder P., Das J.K., Chatterjee M., Kabir S.N., Giri A.K. Chronic arsenic exposure impairs macrophage functions in the exposed individuals. J. Clin. Immunol. 2009, 29:582-594.
14. Banerjee N., Paul S., Sau T.J., Das J.K., Bandyopadhyay A., Banerjee S., Giri A.K. Epigenetic modifications of DAPK and p16 genes contribute to arsenic-induced skin lesions and nondermatological health effects. Toxicol. Sci. 2013, 135:300-308.
15. Bartolome B., Cordoba S., Nieto S., Fernández-Herrera J., García-Díez A. Acute arsenic poisoning: clinical and histopathological features. Br. J. Dermatol. 1999, 141:1106-1109.
16. Bashir S., Sharma Y., Irshad M., Nag T.C., Tiwari M., Kabra M., Dogra T.D. Arsenic induced apoptosis in rat liver following repeated 60 days exposure. Toxicology 2006, 217:63-70.
17. Benbrahim-Tallaa L., Waalkes M.P. Inorganic arsenic and human prostate cancer. Environ. Health Perspect. 2008, 116:158-164.
18. Benowitz N.L. Cardiotoxicity in the workplace. Occup. Med. 1992, 7:465-478.
19. Bestor T.H. The DNA methyltransferases of mammals. Hum. Mol. Genet. 2000, 9:2395-2402.
20. Biswas D., Banerjee M., Sen G., Das J.K., Banerjee A., Sau T.J., Pandit S., Giri A.K., Biswas T. Mechanism of erythrocyte death in human population exposed to arsenic through drinking water. Toxicol. Appl. Pharmacol. 2008, 230:57-66.
21. Celik I., Gallicchio L., Boyd K., Lam T.K., Matanoski G., Tao X., Shiels M., Hammond E., Chen L., Robinson K.A. Arsenic in drinking water and lung cancer: a systematic review. Environ. Res. 2008, 108:48-55.
22. Chakraborti D., Mukherjee S.C., Pati S., Sengupta M.K., Rahman M.M., Chowdhury U.K., Lodh D., Chanda C.R., Chakraborti A.K., Basu G.K. Arsenic groundwater contamination in Middle Ganga Plain, Bihar, India: a future danger?. Environ. Health Perspect. 2003, 111:1194-1201.
23. Chang C.C., Ho S.C., Tsai S.S., Yang C.Y. Ischemic heart disease mortality reduction in an arseniasis-endemic area in southwestern Taiwan after a switch in the tap-water supply system. J. Toxicol. Environ. Health A 2004, 67:1353-1361.
24. Chen C.-J., Hsueh Y.-M., Lai M.-S., Shyu M.-P., Chen S.-Y., Wu M.-M., Kuo T.-L., Tai T.-Y. Increased prevalence of hypertension and long-term arsenic exposure. Hypertension 1995, 25:53-60.
25. Chen C.-J., Wang C.-J. Ecological correlation between arsenic level in well water and age-adjusted mortality from malignant neoplasms. Cancer Res. 1990, 50:5470-5474.
26. Chen C.L., Hsu L.I., Chiou H.Y., Hsueh Y.M., Chen S.Y., Wu M.M., Chen C.J. Ingested arsenic, cigarette smoking, and lung cancer risk: a follow-up study in arseniasis-endemic areas in Taiwan. J. Am. Med. Assoc. 2004, 292:2984-2990. Blackfoot Disease Study, G.
27. Chen Y.-C., Su H.-J.J., Guo Y.-L.L., Hsueh Y.-M., Smith T.J., Ryan L.M., Lee M.-S., Christiani D.C. Arsenic methylation and bladder cancer risk in Taiwan. Cancer Causes Control 2003, 14:303-310.
28. Chen Y., Ahsan H., Slavkovich V., Peltier G.L., Gluskin R.T., Parvez F., Liu X., Graziano J.H. No association between arsenic exposure from drinking water and diabetes mellitus: a cross-sectional study in Bangladesh. Environ. Health Perspect. 2010, 118:1299-1305.
29. Chen Y., Factor-Litvak P., Howe G.R., Graziano J.H., Brandt-Rauf P., Parvez F., van Geen A., Ahsan H. Arsenic exposure from drinking water, dietary intakes of B vitamins and folate, and risk of high blood pressure in Bangladesh: a population-based, cross-sectional study. Am. J. Epidemiol. 2007, 165:541-552.
30. Chen Y., Graziano J.H., Parvez F., Liu M., Slavkovich V., Kalra T., Argos M., Islam T., Ahmed A., Rakibuz-Zaman M., Hasan R., Sarwar G., Levy D., van Geen A., Ahsan H. Arsenic exposure from drinking water and mortality from cardiovascular disease in Bangladesh: prospective cohort study. Br. Med. J 2011, 342:d2431.
31. Chen Y., Karagas M.R. Arsenic and cardiovascular disease: new evidence from the United States. Ann. Intern. Med. 2013, 159:713-714.
32. Chen Y., Parvez F., Gamble M., Islam T., Ahmed A., Argos M., Graziano J.H., Ahsan H. Arsenic exposure at low-to-moderate levels and skin lesions, arsenic metabolism, neurological functions, and biomarkers for respiratory and cardiovascular diseases: review of recent findings from the Health Effects of Arsenic Longitudinal Study (HEALS) in Bangladesh. Toxicol. Appl. Pharmacol. 2009, 239:184-192.
33. Chen Y., Wu F., Parvez F., Ahmed A., Eunus M., McClintock T.R., Patwary T.I., Islam T., Ghosal A.K., Islam S., Hasan R., Levy D., Sarwar G., Slavkovich V., van Geen A., Graziano J.H., Ahsan H. Arsenic exposure from drinking water and QT-interval prolongation: results from the Health Effects of Arsenic Longitudinal Study. Environ. Health Perspect. 2013, 121:427-432.
34. Cherry N., Shaikh K., McDonald C., Chowdhury Z. Stillbirth in rural Bangladesh: arsenic exposure and other etiological factors: a report from Gonoshasthaya Kendra. Bull. World Health Organ. 2008, 86:172-177.
35. Chiou H.-Y., Chiou S.-T., Hsu Y.-H., Chou Y.-L., Tseng C.-H., Wei M.-L., Chen C.-J. Incidence of transitional cell carcinoma and arsenic in drinking water: a follow-up study of 8,102 residents in an arseniasis-endemic area in northeastern Taiwan. Am. J. Epidemiol. 2001, 153:411-418.
36. Chiou H.-Y., Hsueh Y.-M., Liaw K.-F., Horng S.-F., Chiang M.-H., Pu Y.-S., Lin J.S.-N., Huang C.-H., Chen C.-J. Incidence of internal cancers and ingested inorganic arsenic: a seven-year follow-up study in Taiwan. Cancer Res. 1995, 55:1296-1300.
37. Chiou H.Y., Huang W.I., Su C.L., Chang S.F., Hsu Y.H., Chen C.J. Dose-response relationship between prevalence of cerebrovascular disease and ingested inorganic arsenic. Stroke 1997, 28:1717-1723.
38. Ciarrocca M., Tomei F., Caciari T., Cetica C., Andre J.C., Fiaschetti M., Schifano M.P., Scala B., Scimitto L., Tomei G., Sancini A. Exposure to arsenic in urban and rural areas and effects on thyroid hormones. Inhal. Toxicol. 2012, 24:589-598.
39. Collotta M., Bertazzi P.A., Bollati V. Epigenetics and pesticides. Toxicology 2013, 307:35-41.
40. Coronado-Gonzalez J.A., Del Razo L.M., Garcia-Vargas G., Sanmiguel-Salazar F., Escobedo-de la Pena J. Inorganic arsenic exposure and type 2 diabetes mellitus in Mexico. Environ. Res. 2007, 104:383-389.
41. Crawford E.D. Epidemiology of prostate cancer. Urology 2003, 62:3-12.
42. Cui X., Wakai T., Shirai Y., Yokoyama N., Hatakeyama K., Hirano S. Arsenic trioxide inhibits DNA methyltransferase and restores methylation-silenced genes in human liver cancer cells. Hum. Pathol. 2006, 37:298-311.
43. Das N., Paul S., Chatterjee D., Banerjee N., Majumder N., Sarma N., Sau T., Basu S., Banerjee S., Majumder P., Bandyopadhyay A., States J.C., Giri A. Arsenic exposure through drinking water increases the risk of liver and cardiovascular diseases in the population of West Bengal, India. BMC Public Health 2012, 12:639.
44. Dastgiri S., Mosaferi M., Fizi M.A.H., Olfati N., Zolali S., Pouladi N., Azarfam P. Arsenic exposure, dermatological lesions, hypertension, and chromosomal abnormalities among people in a rural community of Northwest Iran. J. Health Popul. Nutr. 2010, 28:14-22.
45. Dauphiné D.C., Ferreccio C., Guntur S., Yuan Y., Hammond S.K., Balmes J., Smith A.H., Steinmaus C. Lung function in adults following in utero and childhood exposure to arsenic in drinking water: preliminary findings. Int. Arch. Occup. Environ. Health 2011, 84:591-600.
46. Dauphiné D.C., Smith A.H., Yuan Y., Balmes J.R., Bates M.N., Steinmaus C. Case-control study of arsenic in drinking water and lung cancer in California and Nevada. Int. J. Environ. Res. Public Health 2013, 10:3310-3324.
47. Davey J.C., Bodwell J.E., Gosse J.A., Hamilton J.W. Arsenic as an endocrine disruptor: effects of arsenic on estrogen receptor-mediated gene expression in vivo and in cell culture. Toxicol. Sci. 2007, 98:75-86.
48. Davey J.C., Nomikos A.P., Wungjiranirun M., Sherman J.R., Ingram L., Batki C., Lariviere J.P., Hamilton J.W. Arsenic as an endocrine disruptor: arsenic disrupts retinoic acid receptor-and thyroid hormone receptor-mediated gene regulation and thyroid hormone-mediated amphibian tail metamorphosis. Environ. Health Perspect. 2008, 116:165-172.
49. Davila-Esqueda M.E., Jimenez-Capdeville M.E., Delgado J.M., De la Cruz E., Aradillas-Garcia C., Jimenez-Suarez V., Escobedo R.F., Llerenas J.R. Effects of arsenic exposure during the pre- and postnatal development on the puberty of female offspring. Exp. Toxicol. Pathol. 2012, 64:25-30.
50. Del Razo L., Garcia-Vargas G., Valenzuela O., Castellanos E., Sanchez-Pena L., Currier J., Drobna Z., Loomis D., Styblo M. Exposure to arsenic in drinking water is associated with increased prevalence of diabetes: a cross-sectional study in the Zimapan and Lagunera regions in Mexico. Environ. Health 2011, 10:73.
51. Diaz-Villasenor A., Cruz L., Cebrian A., Hernandez-Ramirez R.U., Hiriart M., Garcia-Vargas G., Bassol S., Sordo M., Gandolfi A.J., Klimecki W.T., Lopez-Carillo L., Cebrian M.E., Ostrosky-Wegman P. Arsenic exposure and calpain-10 polymorphisms impair the function of pancreatic beta-cells in humans: a pilot study of risk factors for T2DM. PLoS ONE 2013, 8:e51642.
52. Eccleston A., DeWitt N., Gunter C., Marte B., Nath D. Epigenetics. Nature 2007, 447:395.
53. El-Demerdash F.M., Yousef M.I., Radwan F.M. Ameliorating effect of curcumin on sodium arsenite-induced oxidative damage and lipid peroxidation in different rat organs. Food Chem. Toxicol. 2009, 47:249-254.
54. Farzan S.F., Karagas M.R., Chen Y. In utero and early life arsenic exposure in relation to long-term health and disease. Toxicol. Appl. Pharmacol. 2013, 272:384-390.
55. Feinberg A.P., Tycko B. The history of cancer epigenetics. Nat. Rev. Cancer 2004, 4:143-153.
56. Ferreccio C., González C., Milosavjlevic V., Marshall G., Sancha A.M., Smith A.H. Lung cancer and arsenic concentrations in drinking water in Chile. Epidemiology 2000, 11:673-679.
57. Ferreccio C., Smith A.H., Durán V., Barlaro T., Benítez H., Valdés R., Aguirre J.J., Moore L.E., Acevedo J., Vásquez M.I., Pérez L., Yuan Y., Liaw J., Cantor K.P., Steinmaus C. Case-control study of arsenic in drinking water and kidney cancer in uniquely exposed northern Chile. Am. J. Epidemiol. 2013, 178:813-818.
58. Ferreccio C., Yuan Y., Calle J., Benítez H., Parra R.L., Acevedo J., Smith A.H., Liaw J., Steinmaus C. Arsenic, tobacco smoke, and occupation: associations of multiple agents with lung and bladder cancer. Epidemiology 2013, 24:898-905.
59. Feussner J.R., Shelburne J.D., Bredehoeft S., Cohen H.J. Arsenic-induced bone marrow toxicity: ultrastructural and electron-probe analysis. Blood 1979, 53:820-827.
60. Ficker E., Kuryshev Y.A., Dennis A.T., Obejero-Paz C., Wang L., Hawryluk P., Wible B.A., Brown A.M. Mechanisms of arsenic-induced prolongation of cardiac repolarization. Mol. Pharmacol. 2004, 66:33-44.
61. Flora S.J., Mehta A. Monoisoamyl dimercaptosuccinic acid abrogates arsenic-induced developmental toxicity in human embryonic stem cell-derived embryoid bodies: comparison with in vivo studies. Biochem. Pharmacol. 2009, 78:1340-1349.
62. Gibb H., Haver C., Gaylor D., Ramasamy S., Lee J.S., Lobdell D., Wade T., Chen C., White P., Sams R. Utility of recent studies to assess the National Research Council 2001 estimates of cancer risk from ingested arsenic. Environ. Health Perspect. 2011, 119:284-290.
63. Goggin S.L., Labrecque M.T., Allan A.M. Perinatal exposure to 50 ppb sodium arsenate induces hypothalamic-pituitary-adrenal axis dysregulation in male C57BL/6 mice. Neurotoxicology 2012, 33:1338-1345.
64. Goldenberg I., Moss A.J., Zareba W. QT interval: how to measure it and what is "normal". J. Cardiovasc. Electrophysiol. 2006, 17:333-336.
65. Goldsmith S., From A.H. Arsenic-induced atypical ventricular tachycardia. N. Engl. J. Med. 1980, 303:1096-1098.
66. Golub M.S., Macintosh M.S., Baumrind N. Developmental and reproductive toxicity of inorganic arsenic: animal studies and human concerns. J. Toxicol. Environ. Health. B: Crit. Rev. 1998, 1:199-241.
67. Gong G., Basom J., Mattevada S., Onger F. Association of hypothyroidism with low-level arsenic exposure in rural West Texas. Environ. Res. 2015, 138C:154-160.
68. Goyer R.A., Clarkson T.W. Toxic effects of metals. Casarett & Doull's Toxicology. The Basic Science of Poisons 1996, McGraw-Hill Health Professions Division, ISBN 71054766. 5th ed. C.D. Klaassen (Ed.).
69. Gribble M.O., Howard B.V., Umans J.G., Shara N.M., Francesconi K.A., Goessler W., Crainiceanu C.M., Silbergeld E.K., Guallar E., Navas-Acien A. Arsenic exposure, diabetes prevalence, and diabetes control in the Strong Heart Study. Am. J. Epidemiol. 2012, 176:865-874.
70. Guha Mazumder D., Purkayastha I., Ghose A., Mistry G., Saha C., Nandy A.K., Das A., Majumdar K.K. Hypertension in chronic arsenic exposure: a case control study in West Bengal. J. Environ. Sci. Health A: Tox. Hazard. Subst. Environ. Eng. 2012, 47:1514-1520.
71. Guha Mazumder D.N. Arsenic and non-malignant lung disease. J. Environ. Sci. Health A: Tox. Hazard. Subst. Environ. Eng. 2007, 42:1859-1867.
72. Guo J.X., Hu L., Yand P.Z., Tanabe K., Miyatalre M., Chen Y. Chronic arsenic poisoning in drinking water in Inner Mongolia and its associated health effects. J. Environ. Sci. Health A: Tox. Hazard. Subst. Environ. Eng. 2007, 42:1853-1858.
73. Guo X., Fujino Y., Kaneko S., Wu K., Xia Y., Yoshimura T. Arsenic contamination of groundwater and prevalence of arsenical dermatosis in the Hetao plain area, Inner Mongolia, China. Mol. Cell. Biochem. 2001, 222:137-140.
74. Haas G.P., Sakr W.A. Epidemiology of prostate cancer. CA. Cancer J. Clin. 1997, 47:273-287.
75. Hall A.H. Chronic arsenic poisoning. Toxicol. Lett. 2002, 128:69-72.
76. Haque R., Mazumder D.G., Samanta S., Ghosh N., Kalman D., Smith M.M., Mitra S., Santra A., Lahiri S., Das S. Arsenic in drinking water and skin lesions: dose-response data from West Bengal, India. Epidemiology 2003, 14:174-182.
77. Heck J.E., Andrew A.S., Onega T., Rigas J.R., Jackson B.P., Karagas M.R., Duell E.J. Lung cancer in a U.S. population with low to moderate arsenic exposure. Environ. Health Perspect. 2009, 117:1718-1723.
78. Heck J.E., Chen Y., Grann V.R., Slavkovich V., Parvez F., Ahsan H. Arsenic exposure and anemia in Bangladesh: a population-based study. J. Occup. Environ. Med. 2008, 50:80-87.
79. Heerboth S., Lapinska K., Snyder N., Leary M., Rollinson S., Sarkar S. Use of epigenetic drugs in disease: an overview. Genet. Epigenet. 2014, 6:9-19.
80. Henke K.R. Arsenic in natural environments. Arsenic: Environmental Chemistry, Health Threats and Waste Treatment 2009, 69-235. John Wiley & Sons Ltd., Chichester, UK. K. Henke (Ed.).
81. Hong Y.-S., Song K.-H., Chung J.-Y. Health effects of chronic arsenic exposure. J. Prev. Med. Public Health 2014, 47:245-252.
82. Hopenhayn-Rich C., Biggs M.L., Fuchs A., Bergoglio R., Tello E.E., Nicolli H., Smith A.H. Bladder cancer mortality associated with arsenic in drinking water in Argentina. Epidemiology 1996, 7:117-124.
83. Hopenhayn-Rich C., Biggs M.L., Smith A.H. Lung and kidney cancer mortality associated with arsenic in drinking water in Cordoba, Argentina. Int. J. Epidemiol. 1998, 27:561-569.
84. Hopenhayn-Rich C., Browning S.R., Hertz-Picciotto I., Ferreccio C., Peralta C., Gibb H. Chronic arsenic exposure and risk of infant mortality in two areas of Chile. Environ. Health Perspect. 2000, 108:667-673.
85. Hopenhayn C., Ferreccio C., Browning S.R., Huang B., Peralta C., Gibb H., Hertz-Picciotto I. Arsenic exposure from drinking water and birth weight. Epidemiology 2003, 14:593-602.
86. Huang Y.-K., Tseng C.-H., Huang Y.-L., Yang M.-H., Chen C.-J., Hsueh Y.-M. Arsenic methylation capability and hypertension risk in subjects living in arseniasis-hyperendemic areas in southwestern Taiwan. Toxicol. Appl. Pharmacol. 2007, 218:135-142.
87. Hubaux R., Becker-Santos D.D., Enfield K., Rowbotham D., Lam S., Lam W.L., Martinez V.D. Molecular features in arsenic-induced lung tumors. Mol. Cancer 2013, 12:20.
88. Huda N., Hossain S., Rahman M., Karim M.R., Islam K., Mamun A.A., Hossain M.I., Mohanto N.C., Alam S., Aktar S., Arefin A., Ali N., Salam K.A., Aziz A., Saud Z.A., Miyataka H., Himeno S., Hossain K. Elevated levels of plasma uric acid and its relation to hypertension in arsenic-endemic human individuals in Bangladesh. Toxicol. Appl. Pharmacol. 2014, 281:11-18.
89. Hughes M.F. Arsenic toxicity and potential mechanisms of action. Toxicol. Lett. 2002, 133:1-16.
90. IARC Some drinking-water disinfectants and contaminants, including arsenic. IARC Monogr. Eval. Carcinog. Risks Hum. 2004, 84:1-477.
91. Islam M.R., Khan I., Attia J., Hassan S.M., McEvoy M., D'Este C., Azim S., Akhter A., Akter S., Shahidullah S.M., Milton A.H. Association between hypertension and chronic arsenic exposure in drinking water: a cross-sectional study in Bangladesh. Int. J. Environ. Res. Public Health 2012, 9:4522-4536.
92. Islam R., Khan I., Hassan S.N., McEvoy M., D'Este C., Attia J., Peel R., Sultana M., Akter S., Milton A.H. Association between type 2 diabetes and chronic arsenic exposure in drinking water: a cross sectional study in Bangladesh. Environ. Health 2012, 11:38.
93. Järup L., Pershagen G. Arsenic exposure, smoking, and lung cancer in smelter workers-a case-control study. Am. J. Epidemiol. 1991, 134:545-551.
94. Jayasumana M., Paranagama P., Amarasinghe M., Wijewardane K., Dahanayake K., Fonseka S., Rajakaruna K., Mahamithawa A., Samarasinghe U., Senanayake V. Possible link of chronic arsenic toxicity with chronic kidney disease of unknown etiology in Sri Lanka. J. Nat. Sci. Res 2013, 3:64-73.
95. Jiang Y.D., Chang C.H., Tai T.Y., Chen J.F., Chuang L.M. Incidence and prevalence rates of diabetes mellitus in Taiwan: analysis of the 2000-2009 Nationwide Health Insurance database. J. Formos. Med. Assoc. 2012, 111:599-604.
96. Jomova K., Jenisova Z., Feszterova M., Baros S., Liska J., Hudecova D., Rhodes C.J., Valko M. Arsenic: toxicity, oxidative stress and human disease. J. Appl. Toxicol. 2011, 31:95-107.
97. Jones M.R., Tellez-Plaza M., Sharrett A.R., Guallar E., Navas-Acien A. Urine arsenic and hypertension in U.S. adults: the 2003-2008 NHANES. Epidemiology 2011, 22:153-161.
98. Kannan G.M., Tripathi N., Dube S.N., Gupta M., Flora S., Flora S.J. Toxic effects of arsenic(III) on some hematopoietic and central nervous system variables in rats and guinea pigs. Clin. Toxicol. 2001, 39:675-682.
99. Kapaj S., Peterson H., Liber K., Bhattacharya P. Human health effects from chronic arsenic poisoning - a review. J. Environ. Sci. Health A: Tox. Hazard. Subst. Environ. Eng. 2006, 41:2399-2428.
100. Karagas M.R., Tosteson T.D., Blum J., Morris J.S., Baron J.A., Klaue B. Design of an epidemiologic study of drinking water arsenic exposure and skin and bladder cancer risk in a US population. Environ. Health Perspect. 1998, 106:1047-1050.
101. Karagas M.R., Tosteson T.D., Morris J.S., Demidenko E., Mott L.A., Heaney J., Schned A. Incidence of transitional cell carcinoma of the bladder and arsenic exposure in New Hampshire. Cancer Causes Control 2004, 15:465-472.
102. Kim N.H., Mason C.C., Nelson R.G., Afton S.E., Essader A.S., Medlin J.E., Levine K.E., Hoppin J.A., Lin C., Knowler W.C., Sandler D.P. Arsenic exposure and incidence of type 2 diabetes in Southwestern American Indians. Am. J. Epidemiol. 2013, 177:962-969.
103. Kleefstra T., Schenck A., Kramer J.M., van Bokhoven H. The genetics of cognitive epigenetics. Neuropharmacology 2014, 80:83-94.
104. Kligerman A., Tennant A. Insights into the carcinogenic mode of action of arsenic. Toxicol. Appl. Pharmacol. 2007, 222:281-288.
105. Kokilavani V., Devi M.A., Sivarajan K., Panneerselvam C. Combined efficacies of dl-alpha-lipoic acid and meso 2,3 dimercaptosuccinic acid against arsenic induced toxicity in antioxidant systems of rats. Toxicol. Lett. 2005, 160:1-7.
106. Kurttio P., Pukkala E., Kahelin H., Auvinen A., Pekkanen J. Arsenic concentrations in well water and risk of bladder and kidney cancer in Finland. Environ. Health Perspect. 1999, 107:705.
107. Kwok R.K., Kaufmann R.B., Jakariya M. Arsenic in drinking-water and reproductive health outcomes: a study of participants in the Bangladesh Integrated Nutrition Programme. J. Health Popul. Nutr. 2006, 24:190-205.
108. Lambrou A., Baccarelli A., Wright R.O., Weisskopf M., Bollati V., Amarasiriwardena C., Vokonas P., Schwartz J. Arsenic exposure and DNA methylation among elderly men. Epidemiology 2012, 23:668-676.
109. Lamm S.H., Engel A., Kruse M.B., Feinleib M., Byrd D.M., Lai S., Wilson R. Arsenic in drinking water and bladder cancer mortality in the United States: an analysis based on 133 US counties and 30 years of observation. J. Occup. Environ. Med. 2004, 46:298-306.
110. Lamm S.H., Robbins S.A., Zhou C., Lu J., Chen R., Feinleib M. Bladder/lung cancer mortality in Blackfoot-disease (BFD)-endemic area villages with low (<150μg/L) well water arsenic levels - an exploration of the dose-response Poisson analysis. Regul. Toxicol. Pharmacol. 2013, 65:147-156.
111. Lan J., Hua S., He X., Zhang Y. DNA methyltransferases and methyl-binding proteins of mammals. Acta Biochim. Biophys. Sin. 2010, 42:243-252.
112. Lee M.Y., Lee Y.H., Lim K.M., Chung S.M., Bae O.N., Kim H., Lee C.R., Park J.D., Chung J.H. Inorganic arsenite potentiates vasoconstriction through calcium sensitization in vascular smooth muscle. Environ. Health Perspect. 2005, 113:1330-1335.
113. Lemarie A., Morzadec C., Bourdonnay E., Fardel O., Vernhet L. Human macrophages constitute targets for immunotoxic inorganic arsenic. J. Immunol. 2006, 177:3019-3027.
114. Leonardi G., Vahter M., Clemens F., Goessler W., Gurzau E., Hemminki K., Hough R., Koppova K., Kumar R., Rudnai P. Inorganic arsenic and basal cell carcinoma in areas of Hungary, Romania, and Slovakia: a case-control study. Environ. Health Perspect. 2012, 120:721-726.
115. Lewis D.R., Southwick J.W., Ouellet-Hellstrom R., Rench J., Calderon R.L. Drinking water arsenic in Utah: a cohort mortality study. Environ. Health Perspect. 1999, 107:359-365.
116. Lewtas J. Air pollution combustion emissions: characterization of causative agents and mechanisms associated with cancer, reproductive, and cardiovascular effects. Mutat. Res. 2007, 636:95-133.
117. Li D., Lu C., Wang J., Hu W., Cao Z., Sun D., Xia H., Ma X. Developmental mechanisms of arsenite toxicity in zebrafish (Danio rerio) embryos. Aquat. Toxicol. 2009, 91:229-237.
118. Li X., Li B., Xi S., Zheng Q., Lv X., Sun G. Prolonged environmental exposure of arsenic through drinking water on the risk of hypertension and type 2 diabetes. Environ. Sci. Pollut. Res. 2013, 20:8151-8161.
119. Li X., Ma Y., Li D., Gao X., Li P., Bai N., Luo M., Tan X., Lu C., Ma X. Arsenic impairs embryo development via down-regulating Dvr1 expression in zebrafish. Toxicol. Lett. 2012, 212:161-168.
120. Liaw J., Marshall G., Yuan Y., Ferreccio C., Steinmaus C., Smith A.H. Increased childhood liver cancer mortality and arsenic in drinking water in northern Chile. Cancer Epidemiol. Biomarkers Prev. 2008, 17:1982-1987.
121. Lin H.-J., Sung T.-I., Chen C.-Y., Guo H.-R. Arsenic levels in drinking water and mortality of liver cancer in Taiwan. J. Hazard. Mater. 2013, 262:1132-1138.
122. Lindberg A.-L., Rahman M., Persson L.-Å., Vahter M. The risk of arsenic induced skin lesions in Bangladeshi men and women is affected by arsenic metabolism and the age at first exposure. Toxicol. Appl. Pharmacol. 2008, 230:9-16.
123. Liu J., Waalkes M.P. Liver is a target of arsenic carcinogenesis. Toxicol. Sci. 2008, 105:24-32.
124. Liu J., Zheng B.S., Aposhian H.V., Zhou Y.S., Chen M.L., Zhang A.H., Waalkes M.P. Chronic arsenic poisoning from burning high-arsenic-containing coal in Guizhou, China. J. Peripher. Nerv. Syst. 2002, 7:208.
125. Lokuge K.M., Smith W., Caldwell B., Dear K., Milton A.H. The effect of arsenic mitigation interventions on disease burden in Bangladesh. Environ. Health Perspect. 2004, 112:1172-1177.
126. Lu M., Wang H., Li X.F., Lu X., Cullen W.R., Arnold L.L., Cohen S.M., Le X.C. Evidence of hemoglobin binding to arsenic as a basis for the accumulation of arsenic in rat blood. Chem. Res. Toxicol. 2004, 17:1733-1742.
127. Lu T.H., Su C.C., Chen Y.W., Yang C.Y., Wu C.C., Hung D.Z., Chen C.H., Cheng P.W., Liu S.H., Huang C.F. Arsenic induces pancreatic beta-cell apoptosis via the oxidative stress-regulated mitochondria-dependent and endoplasmic reticulum stress-triggered signaling pathways. Toxicol. Lett. 2011, 201:15-26.
128. Lund G., Zaina S. Atherosclerosis: an epigenetic balancing act that goes wrong. Curr. Atheroscler. Rep. 2011, 13:208-214.
129. Luo J.-H., Qiu Z.-Q., Shu W.-Q., Zhang Y.-Y., Zhang L., Chen J.-A. Effects of arsenic exposure from drinking water on spatial memory, ultra-structures and NMDAR gene expression of hippocampus in rats. Toxicol. Lett. 2009, 184:121-125.
130. Madden E.F., Fowler B.A. Mechanisms of nephrotoxicity from metal combinations: a review. Drug Chem. Toxicol. 2000, 23:1-12.
131. Makris K.C., Christophi C.A., Paisi M., Ettinger A.S. A preliminary assessment of low level arsenic exposure and diabetes mellitus in Cyprus. BMC Public Health 2012, 12:334.
132. Mandal B.K., Ogra Y., Suzuki K.T. Identification of dimethylarsinous and monomethylarsonous acids in human urine of the arsenic-affected areas in West Bengal, India. Chem. Res. Toxicol. 2001, 14:371-378.
133. Manna P., Sinha M., Sil P. Arsenic-induced oxidative myocardial injury: protective role of arjunolic acid. Arch. Toxicol. 2008, 82:137-149.
134. Marsit C.J. Influence of environmental exposure on human epigenetic regulation. J. Exp. Biol. 2015, 218:71-79.
135. Martin-Chouly C., Morzadec C., Bonvalet M., Galibert M.-D., Fardel O., Vernhet L. Inorganic arsenic alters expression of immune and stress response genes in activated primary human T lymphocytes. Mol. Immunol. 2011, 48:956-965.
136. Mathew L., Vale A., Adcock J.E. Arsenical peripheral neuropathy. Pract. Neurol. 2010, 10:34-38.
137. Mazumder D.N., Das Gupta J., Santra A., Pal A., Ghose A., Sarkar S. Chronic arsenic toxicity in west Bengal - the worst calamity in the world. J. Indian Med. Assoc. 1998, 96:4-7.
138. McCarty K.M., Hanh H.T., Kim K.-W. Arsenic geochemistry and human health in South East Asia. Rev. Environ. Health 2011, 26:71-78.
139. Medrano M.A., Boix R., Pastor-Barriuso R., Palau M., Damian J., Ramis R., Del Barrio J.L., Navas-Acien A. Arsenic in public water supplies and cardiovascular mortality in Spain. Environ. Res. 2010, 110:448-454.
140. Meliker J.R., Slotnick M.J., AvRuskin G.A., Schottenfeld D., Jacquez G.M., Wilson M.L., Goovaerts P., Franzblau A., Nriagu J.O. Lifetime exposure to arsenic in drinking water and bladder cancer: a population-based case-control study in Michigan, USA. Cancer Causes Control 2010, 21:745-757.
141. Meliker J.R., Wahl R.L., Cameron L.L., Nriagu J.O. Arsenic in drinking water and cerebrovascular disease, diabetes mellitus, and kidney disease in Michigan: a standardized mortality ratio analysis. Environ. Health 2007, 6:4.
142. Milton A.H., Smith W., Rahman B., Hasan Z., Kulsum U., Dear K., Rakibuddin M., Ali A. Chronic arsenic exposure and adverse pregnancy outcomes in Bangladesh. Epidemiology 2005, 16:82-86.
143. Moon K., Guallar E., Navas-Acien A. Arsenic exposure and cardiovascular disease: an updated systematic review. Curr. Atheroscler. Rep. 2012, 14:542-555.
144. Moore S.E., Prentice A.M., Wagatsuma Y., Fulford A.J.C., Collinson A.C., Raqib R., Vahter M., Persson L., Arifeen S.E. Early-life nutritional and environmental determinants of thymic size in infants born in rural Bangladesh. Acta Paediatr. 2009, 98:1168-1175.
145. Mordukhovich I., Wright R.O., Amarasiriwardena C., Baja E., Baccarelli A., Suh H., Sparrow D., Vokonas P., Schwartz J. Association between low-level environmental arsenic exposure and QT interval duration in a general population study. Am. J. Epidemiol. 2009, 170:739-746.
146. Mostafa M.G., McDonald J.C., Cherry N.M. Lung cancer and exposure to arsenic in rural Bangladesh. Occup. Environ. Med. 2008, 65:765-768.
147. Mukherjee S.C., Rahman M.M., Chowdhury U.K., Sengupta M.K., Lodh D., Chanda C.R., Saha K.C., Chakraborti D. Neuropathy in arsenic toxicity from groundwater arsenic contamination in West Bengal, India. J. Environ. Sci. Health A: Tox. Hazard. Subst. Environ. Eng. 2003, 38:165-183.
148. Mumford J.L., Wu K., Xia Y., Kwok R., Yang Z., Foster J., Sanders W.E. Chronic arsenic exposure and cardiac repolarization abnormalities with QT interval prolongation in a population-based study. Environ. Health Perspect. 2007, 115:690-694.
149. Mundey M.K., Roy M., Roy S., Awasthi M.K., Sharma R. Antioxidant potential of Ocimum sanctum in arsenic induced nervous tissue damage. Braz. J. Vet. Pathol. 2013, 6:95-101.
150. Myers S.L., Lobdell D.T., Liu Z., Xia Y., Ren H., Li Y., Kwok R.K., Mumford J.L., Mendola P. Maternal drinking water arsenic exposure and perinatal outcomes in inner Mongolia, China. J. Epidemiol. Community Health 2010, 64:325-329.
151. Namgung U., Xia Z. Arsenic induces apoptosis in rat cerebellar neurons via activation of JNK3 and p38 MAP kinases. Toxicol. Appl. Pharmacol. 2001, 174:130-138.
152. Nanney D.L. Epigenetic control systems. Proc. Natl. Acad. Sci. U. S. A. 1958, 44:712-717.
153. Naujokas M.F., Anderson B., Ahsan H., Aposhian H.V., Graziano J.H., Thompson C., Suk W.A. The broad scope of health effects from chronic arsenic exposure: update on a worldwide public health problem. Environ. Health Perspect. 2013, 121:295-302.
154. Navas-Acien A., Sharrett A.R., Silbergeld E.K., Schwartz B.S., Nachman K.E., Burke T.A., Guallar E. Arsenic exposure and cardiovascular disease: a systematic review of the epidemiologic evidence. Am. J. Epidemiol. 2005, 162:1037-1049.
155. Navas-Acien A., Silbergeld E.K., Pastor-Barriuso R., Guallar E. Arsenic exposure and prevalence of type 2 diabetes in US adults. J. Am. Med. Assoc. 2008, 300:814-822.
156. Navas-Acien A., Silbergeld E.K., Streeter R.A., Clark J.M., Burke T.A., Guallar E. Arsenic exposure and type 2 diabetes: a systematic review of the experimental and epidemiological evidence. Environ. Health Perspect. 2006, 114:641-648.
157. O'Bryant S.E., Edwards M., Menon C.V., Gong G., Barber R. Long-term low-level arsenic exposure is associated with poorer neuropsychological functioning: a Project FRONTIER study. Int. J. Environ. Res. Public Health 2011, 8:861-874.
158. Ordovas J.M., Smith C.E. Epigenetics and cardiovascular disease. Nat. Rev. Cardiol. 2010, 7:510-519.
159. Ostrosky-Wegman P., Gonsebatt M.E., Montero R., Vega L., Barba H., Espinosa J., Palao A., Cortinas C., Garcia-Vargas G., del Razo L.M., et al. Lymphocyte proliferation kinetics and genotoxic findings in a pilot study on individuals chronically exposed to arsenic in Mexico. Mutat. Res. 1991, 250:477-482.
160. Pakulska D., Czerczak S. Hazardous effects of arsine: a short review. Int. J. Occup. Med. Environ. Health 2006, 19:36-44.
161. Pan W.C., Kile M.L., Seow W.J., Lin X., Quamruzzaman Q., Rahman M., Mahiuddin G., Mostofa G., Lu Q., Christiani D.C. Genetic susceptible locus in NOTCH2 interacts with arsenic in drinking water on risk of type 2 diabetes. PLoS ONE 2013, 8:e70792.
162. Pan W.C., Seow W.J., Kile M.L., Hoffman E.B., Quamruzzaman Q., Rahman M., Mahiuddin G., Mostofa G., Lu Q., Christiani D.C. Association of low to moderate levels of arsenic exposure with risk of type 2 diabetes in Bangladesh. Am. J. Epidemiol. 2013, 178:1563-1570.
163. Parrish A.R., Zheng X.H., Turney K.D., Younis H.S., Gandolfi A.J. Enhanced transcription factor DNA binding and gene expression induced by arsenite or arsenate in renal slices. Toxicol. Sci. 1999, 50:98-105.
164. Parvez F., Chen Y., Brandt-Rauf P.W., Bernard A., Dumont X., Slavkovich V., Argos M.D., Armiento J., Foronjy R., Hasan M.R. Nonmalignant respiratory effects of chronic arsenic exposure from drinking water among never-smokers in Bangladesh. Environ. Health Perspect. 2008, 116:190.
165. Parvez F., Chen Y., Brandt-Rauf P.W., Slavkovich V., Islam T., Ahmed A., Argos M., Hassan R., Yunus M., Haque S.E. A prospective study of respiratory symptoms associated with chronic arsenic exposure in Bangladesh: findings from the Health Effects of Arsenic Longitudinal Study (HEALS). Thorax 2010, 65:528-533.
166. Parvez F., Chen Y., Yunus M., Olopade C., Segers S., Slavkovich V., Argos M., Hasan R., Ahmed A., Islam T. Arsenic exposure and impaired lung function. Findings from a large population-based prospective cohort study. Am. J. Respir. Crit. Care Med. 2013, 188:813-819.
167. Parvez F., Chen Y., Yunus M., Olopade C., Slavkovich V., Graziano J., Ahsan H. E-008: arsenic induced impaired lung function and tuberculosis: findings from health effects of Arsenic Longitudinal Study (HEALS) Cohort, Bangladesh. Epidemiology 2012, 23.
168. Parvez F., Chen Y., Yunus M., Zaman R.-U., Ahmed A., Islam T., Argos M., Hasan R., Slavkovich V., Graziano J. Associations of arsenic exposure with impaired lung function and mortality from diseases of the respiratory system: findings from the health effects of Arsenic Longitudinal Study (HEALS). Epidemiology 2011, 22:S179.
169. Pascual D., Borque A. Epidemiology of kidney cancer. Adv. Urol. 2008, 2008:7.
170. Pilsner J.R., Liu X., Ahsan H., Ilievski V., Slavkovich V., Levy D., Factor-Litvak P., Graziano J.H., Gamble M.V. Folate deficiency, hyperhomocysteinemia, low urinary creatinine, and hypomethylation of leukocyte DNA are risk factors for arsenic-induced skin lesions. Environ. Health Perspect. 2009, 117:254-260.
171. Radosavljević V., Jakovljević B. Arsenic and bladder cancer: observations and suggestions. J. Environ. Health 2008, 71:40-42.
172. Rahman M., Axelson O. Diabetes mellitus and arsenic exposure: a second look at case-control data from a Swedish copper smelter. Occup. Environ. Med. 1995, 52:773-774.
173. Rahman M., Tondel M., Ahmad S.A., Axelson O. Diabetes mellitus associated with arsenic exposure in Bangladesh. Am. J. Epidemiol. 1998, 148:198-203.
174. Rahman M., Tondel M., Ahmad S.A., Chowdhury I.A., Faruquee M.H., Axelson O. Hypertension and arsenic exposure in Bangladesh. Hypertension 1999, 33:74-78.
175. Rahman M., Wingren G., Axelson O. Diabetes mellitus among Swedish art glass workers - an effect of arsenic exposure?. Scand. J. Work. Environ. Health 1996, 22:146-149.
176. Rahman M.M., Ng J.C., Naidu R. Chronic exposure of arsenic via drinking water and its adverse health impacts on humans. Environ. Geochem. Health 2009, 31(Suppl. 1):189-200.
177. Ramsey K.A., Foong R.E., Sly P.D., Larcombe A.N., Zosky G.R. Early life arsenic exposure and acute and long-term responses to influenza A infection in mice. Environ. Health Perspect. 2013, 121:1187-1193.
178. Raqib R., Ahmed S., Sultana R., Wagatsuma Y., Mondal D., Hoque A.M.W., Nermell B., Yunus M., Roy S., Persson L.A., Arifeen S.E., Moore S., Vahter M. Effects of in utero arsenic exposure on child immunity and morbidity in rural Bangladesh. Toxicol. Lett. 2009, 185:197-202.
179. Ratnaike R.N. Acute and chronic arsenic toxicity. Postgrad. Med. J. 2003, 79:391-396.
180. Recio-Vega R., Gonzalez-Cortes T., Olivas-Calderon E., Lantz R.C., Gandolfi A.J., Alba C.G. In utero and early childhood exposure to arsenic decreases lung function in children. J. Appl. Toxicol. 2014.
181. Reichard J.F., Puga A. Effects of arsenic exposure on DNA methylation and epigenetic gene regulation. Epigenomics 2010, 2:87-104.
182. Ren X., McHale C.M., Skibola C.F., Smith A.H., Smith M.T., Zhang L. An emerging role for epigenetic dysregulation in arsenic toxicity and carcinogenesis. Environ. Health Perspect. 2011, 119:11-19.
183. Rodriguez V., Carrizales L., Mendoza M., Fajardo O., Giordano M. Effects of sodium arsenite exposure on development and behavior in the rat. Neurotoxicol. Teratol. 2002, 24:743-750.
184. Rodriguez V.M., Jimenez-Capdeville M.E., Giordano M. The effects of arsenic exposure on the nervous system. Toxicol. Lett. 2003, 145:1-18.
185. Rudenko A., Tsai L.H. Epigenetic modifications in the nervous system and their impact upon cognitive impairments. Neuropharmacology 2014, 80:70-82.
186. Saha J., Dikshit A., Bandyopadhyay M., Saha K. A review of arsenic poisoning and its effects on human health. Crit. Rev. Environ Sci. Technol. 1999, 29:281-313.
187. Sakurai T., Ohta T., Tomita N., Kojima C., Hariya Y., Mizukami A., Fujiwara K. Evaluation of immunotoxic and immunodisruptive effects of inorganic arsenite on human monocytes/macrophages. Int. Immunopharmacol. 2006, 6:304-315.
188. Sanchez-Pena L.C., Petrosyan P., Morales M., Gonzalez N.B., Gutierrez-Ospina G., Del Razo L.M., Gonsebatt M.E. Arsenic species, AS3MT amount, and AS3MT gene expression in different brain regions of mouse exposed to arsenite. Environ. Res. 2010, 110:428-434.
189. Sarkar S., Horn G., Moulton K., Oza A., Byler S., Kokolus S., Longacre M. Cancer development, progression, and therapy: an epigenetic overview. Int. J. Mol. Sci. 2013, 14:21087-21113.
190. Sasaki A., Oshima Y., Fujimura A. An approach to elucidate potential mechanism of renal toxicity of arsenic trioxide. Exp. Hematol. 2007, 35:252-262.
191. Selgrade M.K. Immunotoxicity: the risk is real. Toxicol. Sci. 2007, 100:328-332.
192. Seow W.J., Kile M.L., Baccarelli A.A., Pan W.C., Byun H.M., Mostofa G., Quamruzzaman Q., Rahman M., Lin X., Christiani D.C. Epigenome-wide DNA methylation changes with development of arsenic-induced skin lesions in Bangladesh: a case-control follow-up study. Environ. Mol. Mutagen. 2014, 55:449-456.
193. Shen H., Xu W., Zhang J., Chen M., Martin F.L., Xia Y., Liu L., Dong S., Zhu Y.G. Urinary metabolic biomarkers link oxidative stress indicators associated with general arsenic exposure to male infertility in a Han Chinese population. Environ. Sci. Technol. 2013, 47:8843-8851.
194. Siegel R., Naishadham D., Jemal A. Cancer statistics, 2013. CA. Cancer J. Clin. 2013, 63:11-30.
195. Simeonova P.P., Hulderman T., Harki D., Luster M.I. Arsenic exposure accelerates atherogenesis in apolipoprotein E(-/-) mice. Environ. Health Perspect. 2003, 111:1744-1748.
196. Simeonova P.P., Luster M.I. Arsenic and atherosclerosis. Toxicol. Appl. Pharmacol. 2004, 198:444-449.
197. Singh M.K., Yadav S.S., Gupta V., Khattri S. Immunomodulatory role of Emblica officinalis in arsenic induced oxidative damage and apoptosis in thymocytes of mice. BMC Complement. Altern. Med. 2013, 13:193.
198. Smeester L., Rager J.E., Bailey K.A., Guan X., Smith N., Garcia-Vargas G., Del Razo L.M., Drobna Z., Kelkar H., Styblo M., Fry R.C. Epigenetic changes in individuals with arsenicosis. Chem. Res. Toxicol. 2011, 24:165-167.
199. Smith A.H., Goycolea M., Haque R., Biggs M.L. Marked increase in bladder and lung cancer mortality in a region of Northern Chile due to arsenic in drinking water. Am. J. Epidemiol. 1998, 147:660-669.
200. Smith A.H., Marshall G., Liaw J., Yuan Y., Ferreccio C., Steinmaus C. Mortality in young adults following in utero and childhood exposure to arsenic in drinking water. Environ. Health Perspect. 2012, 120:1527-1531.
201. Smith Z.D., Chan M.M., Mikkelsen T.S., Gu H., Gnirke A., Regev A., Meissner A. A unique regulatory phase of DNA methylation in the early mammalian embryo. Nature 2012, 484:339-344.
202. Sohel N., Vahter M., Ali M., Rahman M., Rahman A., Streatfield P.K., Kanaroglou P.S., Persson L.A. Spatial patterns of fetal loss and infant death in an arsenic-affected area in Bangladesh. Int. J. Health Geogr. 2010, 9:53.
203. Soto-Peña G.A., Vega L. Arsenic interferes with the signaling transduction pathway of T cell receptor activation by increasing basal and induced phosphorylation of Lck and Fyn in spleen cells. Toxicol. Appl. Pharmacol. 2008, 230:216-226.
204. Srivastava R.K., Li C., Chaudhary S.C., Ballestas M.E., Elmets C.A., Robbins D.J., Matalon S., Deshane J.S., Afaq F., Bickers D.R., Athar M. Unfolded protein response (UPR) signaling regulates arsenic trioxide-mediated macrophage innate immune function disruption. Toxicol. Appl. Pharmacol. 2013, 272:879-887.
205. Srivastava S., Vladykovskaya E.N., Haberzettl P., Sithu S.D., D'Souza S.E., States J.C. Arsenic exacerbates atherosclerotic lesion formation and inflammation in ApoE-/- mice. Toxicol. Appl. Pharmacol. 2009, 241:90-100.
206. States J.C., Srivastava S., Chen Y., Barchowsky A. Arsenic and cardiovascular disease. Toxicol. Sci. 2009, 107:312-323.
207. Steinmaus C., Ferreccio C., Acevedo J., Yuan Y., Liaw J., Duran V., Cuevas S., Garcia J., Meza R., Valdes R., Valdes G., Benitez H., VanderLinde V., Villagra V., Cantor K.P., Moore L.E., Perez S.G., Steinmaus S., Smith A.H. Increased lung and bladder cancer incidence in adults after in utero and early-life arsenic exposure. Cancer Epidemiol. Biomarkers Prev. 2014, 23:1529-1538.
208. Steinmaus C., Yuan Y., Liaw J., Smith A.H. Low-level population exposure to inorganic arsenic in the United States and diabetes mellitus: a reanalysis. Epidemiology 2009, 20:807-815.
209. Sterns J.D., Smith C.B., Steele J.R., Stevenson K.L., Gallicano G.I. Epigenetics and type II diabetes mellitus: underlying mechanisms of prenatal predisposition. Front. Cell Dev. Biol. 2014, 2:15.
210. Straus S.M., Kors J.A., De Bruin M.L., van der Hooft C.S., Hofman A., Heeringa J., Deckers J.W., Kingma J.H., Sturkenboom M.C., Stricker B.H., Witteman J.C. Prolonged QTc interval and risk of sudden cardiac death in a population of older adults. J. Am. Coll. Cardiol. 2006, 47:362-367.
211. Surdu S. Non-melanoma skin cancer: occupational risk from UV light and arsenic exposure. Rev. Environ. Health 2014, 29:255-265.
212. Suzuki T., Tsukamoto I. Arsenite induces apoptosis in hepatocytes through an enhancement of the activation of Jun N-terminal kinase and p38 mitogen-activated protein kinase caused by partial hepatectomy. Toxicol. Lett. 2006, 165:257-264.
213. Suzuki T., Yamashita S., Ushijima T., Takumi S., Sano T., Michikawa T., Nohara K. Genome-wide analysis of DNA methylation changes induced by gestational arsenic exposure in liver tumors. Cancer Sci. 2013, 104:1575-1585.
214. Szymanska-Chabowska A., Antonowicz-Juchniewicz J., Andrzejak R. Some aspects of arsenic toxicity and carcinogenicity in living organism with special regard to its influence on cardiovascular system, blood and bone marrow. Int. J. Occup. Med. Environ. Health 2002, 15:101-116.
215. Tabocova S., Hunter E.S., Gladen B.C. Developmental toxicity of inorganic arsenic in whole embryo: culture oxidation state, dose, time, and gestational age dependence. Toxicol. Appl. Pharmacol. 1996, 138:298-307.
216. Thompson D.J. A chemical hypothesis for arsenic methylation in mammals. Chem. Biol. Interact. 1993, 88:89-114.
217. Tondel M., Rahman M., Magnuson A., Chowdhury I.A., Faruquee M.H., Ahmad S.A. The relationship of arsenic levels in drinking water and the prevalence rate of skin lesions in Bangladesh. Environ. Health Perspect. 1999, 107:727-729.
218. Tsai S.M., Wang T.N., Ko Y.C. Mortality for certain diseases in areas with high levels of arsenic in drinking water. Arch. Environ. Health 1999, 54:186-193.
219. Tseng C.H. An overview on peripheral vascular disease in blackfoot disease-hyperendemic villages in Taiwan. Angiology 2002, 53:529-537.
220. Tseng C.H. The potential biological mechanisms of arsenic-induced diabetes mellitus. Toxicol. Appl. Pharmacol. 2004, 197:67-83.
221. Tseng C.H., Chong C.K., Chen C.J., Tai T.Y. Dose-response relationship between peripheral vascular disease and ingested inorganic arsenic among residents in blackfoot disease endemic villages in Taiwan. Atherosclerosis 1996, 120:125-133.
222. Tseng C.H., Chong C.K., Heng L.T., Tseng C.P., Tai T.Y. The incidence of type 2 diabetes mellitus in Taiwan. Diabetes Res. Clin. Pract. 2000, 50(Suppl. 2):S61-S64.
223. Tseng C.H., Chong C.K., Tseng C.P., Hsueh Y.M., Chiou H.Y., Tseng C.C., Chen C.J. Long-term arsenic exposure and ischemic heart disease in arseniasis-hyperendemic villages in Taiwan. Toxicol. Lett. 2003, 137:15-21.
224. Tseng C.H., Huang Y.K., Huang Y.L., Chung C.J., Yang M.H., Chen C.J., Hsueh Y.M. Arsenic exposure, urinary arsenic speciation, and peripheral vascular disease in blackfoot disease-hyperendemic villages in Taiwan. Toxicol. Appl. Pharmacol. 2005, 206:299-308.
225. Tseng C.H., Tai T.Y., Chong C.K., Tseng C.P., Lai M.S., Lin B.J., Chiou H.Y., Hsueh Y.M., Hsu K.H., Chen C.J. Long-term arsenic exposure and incidence of non-insulin-dependent diabetes mellitus: a cohort study in arseniasis-hyperendemic villages in Taiwan. Environ. Health Perspect. 2000, 108:847-851.
226. Tseng W., Chu H.M., How S., Fong J., Lin C., Yeh S. Prevalence of skin cancer in an endemic area of chronic arsenicism in Taiwan. J. Natl. Cancer Inst. 1968, 40:453-463.
227. Uede K., Furukawa F. Skin manifestations in acute arsenic poisoning from the Wakayama curry-poisoning incident. Br. J. Dermatol. 2003, 149:757-762.
228. Ueki K., Kondo T., Tseng Y.H., Kahn C.R. Central role of suppressors of cytokine signaling proteins in hepatic steatosis, insulin resistance, and the metabolic syndrome in the mouse. Proc. Natl. Acad. Sci. U. S. A. 2004, 101:10422-10427.
229. Vahidnia A., Van der Voet G., De Wolff F. Arsenic neurotoxicity-a review. Hum. Exp. Toxicol. 2007, 26:823-832.
230. Vahter M. Health effects of early life exposure to arsenic. Basic Clin. Pharmacol. Toxicol. 2008, 102:204-211.
231. Vahter M. Effects of arsenic on maternal and fetal health. Annu. Rev. Nutr. 2009, 29:381-399.
232. Vahter M.E., Li L., Nermell B., Rahman A., Arifeen S.E., Rahman M., Persson L.Å., Ekström E.-C. Arsenic exposure in pregnancy: a population-based study in Matlab, Bangladesh. J. Health Popul. Nutr. 2006, 236-245.
233. Vantroyen B., Heilier J.F., Meulemans A., Michels A., Buchet J.P., Vanderschueren S., Haufroid V., Sabbe M. Survival after a lethal dose of arsenic trioxide. Clin. Toxicol. 2004, 42:889-895.
234. Vigeh M., Yokoyama K., Matsukawa T., Shinohara A., Ohtani K. The relation of maternal blood arsenic to anemia during pregnancy. Women Health 2014, 55:42-57.
235. Waddington C.H. The epigenotype. 1942. Int. J. Epidemiol. 2012, 41:10-13.
236. Wang C.-H., Chen C.-L., Hsiao C., Chiang F.-T., Hsu L.-I., Chiou H.-Y., Hsueh Y.-M., Wu M.-M., Chen C.-J. Arsenic-induced QT dispersion is associated with atherosclerotic diseases and predicts long-term cardiovascular mortality in subjects with previous exposure to arsenic: a 17-year follow-up study. Cardiovasc. Toxicol. 2010, 10:17-26.
237. Wang C.H., Chen C.L., Hsiao C.K., Chiang F.T., Hsu L.I., Chiou H.Y., Hsueh Y.M., Wu M.M., Chen C.J. Increased risk of QT prolongation associated with atherosclerotic diseases in arseniasis-endemic area in southwestern coast of Taiwan. Toxicol. Appl. Pharmacol. 2009, 239:320-324.
238. Wang C.H., Hsiao C.K., Chen C.L., Hsu L.I., Chiou H.Y., Chen S.Y., Hsueh Y.M., Wu M.M., Chen C.J. A review of the epidemiologic literature on the role of environmental arsenic exposure and cardiovascular diseases. Toxicol. Appl. Pharmacol. 2007, 222:315-326.
239. Wang C.H., Jeng J.S., Yip P.K., Chen C.L., Hsu L.I., Hsueh Y.M., Chiou H.Y., Wu M.M., Chen C.J. Biological gradient between long-term arsenic exposure and carotid atherosclerosis. Circulation 2002, 105:1804-1809.
240. Wang J.P., Wang S.L., Lin Q., Zhang L., Huang D., Ng J.C. Association of arsenic and kidney dysfunction in people with diabetes and validation of its effects in rats. Environ. Int. 2009, 35:507-511.
241. Wang S.-L., Li W.-F., Chen C.-J., Huang Y.-L., Chen J.-W., Chang K.-H., Tsai L.-Y., Chou K.-M. Hypertension incidence after tap-water implementation: a 13-year follow-up study in the arseniasis-endemic area of southwestern Taiwan. Sci. Total Environ. 2011, 409:4528-4535.
242. Wang W., Cheng S., Zhang D. Association of inorganic arsenic exposure with liver cancer mortality: a meta-analysis. Environ. Res. 2014, 135:120-125.
243. Wang W., Xie Z., Lin Y., Zhang D. Association of inorganic arsenic exposure with type 2 diabetes mellitus: a meta-analysis. J. Epidemiol. Community Health 2014, 68:176-184.
244. Wang Y.H., Wu M.M., Hong C.T., Lien L.M., Hsieh Y.C., Tseng H.P., Chang S.F., Su C.L., Chiou H.Y., Chen C.J. Effects of arsenic exposure and genetic polymorphisms of p53, glutathione S-transferase M1, T1, and P1 on the risk of carotid atherosclerosis in Taiwan. Atherosclerosis 2007, 192:305-312.
245. Wasserman G.A., Liu X., Parvez F., Ahsan H., Factor-Litvak P., van Geen A., Slavkovich V., Lolacono N.J., Cheng Z., Hussain I. Water arsenic exposure and children's intellectual function in Araihazar, Bangladesh. Environ. Health Perspect. 2004, 112:1329-1333.
246. Watanabe T., Hirano S. Metabolism of arsenic and its toxicological relevance. Arch. Toxicol. 2013, 87:969-979.
247. Winski S.L., Carter D.E. Arsenate toxicity in human erythrocytes: characterization of morphologic changes and determination of the mechanism of damage. J. Toxicol. Environ. Health A 1998, 53:345-355.
248. Wu J., Chen G., Liao Y., Song X., Pei L., Wang J., Zheng X. Arsenic levels in the soil and risk of birth defects: a population-based case-control study using GIS technology. J. Environ. Health 2011, 74:20-25.
249. Wu M.M., Chiou H.Y., Ho I.C., Chen C.J., Lee T.C. Gene expression of inflammatory molecules in circulating lymphocytes from arsenic-exposed human subjects. Environ. Health Perspect. 2003, 111:1429-1438.
250. Yamazaki K., Terada H., Satoh H., Naito K., Takeshita A., Uehara A., Katoh H., Ohnishi K., Hayashi H. Arrhythmogenic effects of arsenic trioxide in patients with acute promyelocytic leukemia and an electrophysiological study in isolated guinea pig papillary muscles. Circ. J. 2006, 70:1407-1414.
251. Yang C.Y., Chang C.C., Tsai S.S., Chuang H.Y., Ho C.K., Wu T.N. Arsenic in drinking water and adverse pregnancy outcome in an arseniasis-endemic area in northeastern Taiwan. Environ. Res. 2003, 91:29-34.
252. Yang H.-T., Chou H.-J., Han B.-C., Huang S.-Y. Lifelong inorganic arsenic compounds consumption affected blood pressure in rats. Food Chem. Toxicol. 2007, 45:2479-2487.
253. Yu R.C., Hsu K.-H., Chen C.-J., Froines J.R. Arsenic methylation capacity and skin cancer. Cancer Epidemiol. Biomarkers Prev. 2000, 9:1259-1262.
254. Zhang C., Mao G., He S., Yang Z., Yang W., Zhang X., Qiu W., Ta N., Cao L., Yang H., Guo X. Relationship between long-term exposure to low-level arsenic in drinking water and the prevalence of abnormal blood pressure. J. Hazard. Mater. 2013, 262:1154-1158.
255. Zhang J., Mu X., Xu W., Martin F.L., Alamdar A., Liu L., Tian M., Huang Q., Shen H. Exposure to arsenic via drinking water induces 5-hydroxymethylcytosine alteration in rat. Sci. Total Environ. 2014, 497-498:618-625.
256. Zhang X., Lin S., Funk W.E., Hou L. Environmental and occupational exposure to chemicals and telomere length in human studies. Occup. Environ. Med. 2013, 70:743-749.
257. Zhang Y., Post W.S., Dalal D., Blasco-Colmenares E., Tomaselli G.F., Guallar E. QT-interval duration and mortality rate: results from the Third National Health and Nutrition Examination Survey. Arch. Intern. Med. 2011, 171:1727-1733.
258. Zheng L., Kuo C.C., Fadrowski J., Agnew J., Weaver V.M., Navas-Acien A. Arsenic and chronic kidney disease: a systematic review. Curr. Environ. Health Rep. 2014, 1:192-207.